|
Sign In to gain access to subscriptions and/or personal tools.
|
First published on July 3, 2008, doi:10.1177/1087057108320133
Journal of Biomolecular Screening 2008;13:575.
A more recent version of this article appeared on August 1, 2008
Work Flow for Multiplexing siRNA Assays by Solid-Phase Reverse Transfection in Multiwell Plates
Holger Erfle*,
Rainer Pepperkok,
Jan Ellenberg,
Jutta Bulkescher,
Beate Neumann,
and
Phill Rogers
BIOQUANT Centre University Heidelberg
* To whom correspondence should be addressed. E-mail: holger.erfle{at}bioquant.uni-heidelberg.de.
 |
Abstract |
|---|
5Solid-phase reverse transfection on cell microarrays is a high-throughput method for the parallel transfection of mammalian cells. However, the cells transfected in this way have been restricted so far to microscopy-based analyses. Analysis methods such as reverse transcriptase–polymerase chain reaction (RT-PCR) and access to higher cell numbers for statistical reasons in microscopy-based assays are not possible with solid-phase reverse transfection on cell microarrays. We have developed a quick and reliable protocol for automated solid-phase reverse transfection of human cells with siRNAs in multiwell plates complementing solid-phase reverse transfection on cell microarrays. The method retains all advantages of solid-phase reverse transfection such as long-term storage capacity after fabrication, reduced cytotoxicity, and reduced cost per screen compared with liquid-phase transfection in multiwell plates. The protocol has been tested for the RNAi-mediated knockdown of several genes in different cell lines including U20S, RPE1, A549, and HeLa cells. We show that even 3 months after production of the "ready to transfect" multiwell plates, there is no reduction in their transfection efficiency as assessed by RT-PCR and nuclear phenotyping by fluorescence microscopy. We conclude that solid-phase reverse transfection in multiwell plates is a cost-efficient and flexible tool for multiplexing cellular assays. (Journal of Biomolecular Screening. XXXX:xx-xx)

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
|